Leonteq Securities AG
Broker-DealerPosition in TNXP — Tonix Pharmaceuticals Holding Corp.
CIK 1535950
ZURICH, V8
Position in TNXP
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$78,375
-$10,659 QoQ
Shares Held
5,700
0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Leonteq Securities AG holds $25,859,639 across 58 Biotechnology names. TNXP ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
302,375 | $15,360,650 | |
| 2 | BNTX |
BioNTech SE
|
26,784 | $2,380,561 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,260 | $1,902,260 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,212 | $936,439 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
22,812 | $742,302 | |
| 6 | IOVA |
Iovance Biotherapeutics, Inc.
|
160,000 | $561,600 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
2,644 | $446,888 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
12,367 | $294,705 |
All Filings in TNXP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,375 | 5,700 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $89,034 | 5,700 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $16,912 | 700 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||